| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Inc / Ma (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $60.48M | - | |
| COO | 63.4K | $28.71M | - | |
| VP | 51.1K | $23.14M | - | |
| VP | 42.3K | $19.16M | - | |
| Other | 24.0K | $10.89M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2024 | Leiden Jeffrey M47 | Executive Chairman | Sell | 9,011 | $419.10 | $3,776,528.04 | -18.2% | +2.6% | +7.7% | |
| Feb 13, 2024 | Leiden Jeffrey M47 | Executive Chairman | Sell | 3,393 | $419.42 | $1,423,104.12 | -3.9% | +3.3% | +8.9% | |
| Feb 12, 2024 | Atkinson Edward Morrow III49 | EVP, Chief Technical Ops. Off. | Sell | 913 | $420.24 | $383,679.12 | -3.8% | +2.7% | +8.8% | |
| Feb 12, 2024 | Tatsis Ourania48 | EVP, Chief Reg. &Quality Off. | Sell | 314 | $420.24 | $131,955.36 | -0.5% | +2.7% | +8.8% | |
| Feb 12, 2024 | Sachdev Amit | EVP Chief Patient &Ext Af Off | Sell | 3,222 | $420.24 | $1,354,013.28 | -4.2% | +2.7% | +8.8% | |
| Feb 12, 2024 | Biller Jonathan46 | EVP And Chief Legal Officer | Sell | 1,738 | $418.77 | $727,822.26 | -8.7% | +2.7% | +8.8% | |
| Feb 12, 2024 | Arbuckle Stuart A | EVP, COO | Sell | 4,295 | $420.24 | $1,804,930.80 | -5.4% | +2.7% | +8.8% | |
| Feb 12, 2024 | Ambrose Kristen | SVP &Chief Accounting Officer | Sell | 1,374 | $420.24 | $577,409.76 | -12.4% | +2.7% | +8.8% | |
| Feb 12, 2024 | Altshuler David48 | EVP, Global Research And CSO | Sell | 3,145 | $420.24 | $1,321,654.80 | -6.2% | +2.7% | +8.8% | |
| Jan 8, 2024 | Leiden Jeffrey M47 | Executive Chairman | Sell | 6,648 | $419.07 | $2,785,977.36 | -73.3% | -3.6% | -2.6% |